Immune transcriptome and antibody response in adult-onset Still's disease with mild flare following administration of mRNA vaccine BNT162b2.

The article describes the case of a 58-year-old male who experienced a mild adult-onset Still's disease (AOSD) flare following second BNT162b2 vaccine. Topics discussed include result of treatment with prednisolone, the patient's diagnosis with AOSD in 2013, and comparison of the patient's antibody response with those from healthy individuals within the first seven days after second BNT162b2 vaccination.